We spent last tweek in Tbilisi, Georgia, to prepare the start of our 2 new CT to evaluate hostdirected therapies: ibuprofen and the nutraceutical Nyaditum resae. A pilot CT will evaluate ibuprofen as coadjuvant treatment for Pre-XDR and XDR-TB; and an efficacy trial will evaluate Nyaditum resae, the food supplement our spin-off Manremyc is developing. We are excited about our ongoing studies in this wonderful site. You can learn more about both trials in our Projects page at Research lines and Team
Enjoy here below the pictures!